1. Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial. Issue 3 (11th November 2018) Authors: Bain, Stephen C.; Mosenzon, Ofri; Arechavaleta, Rosario; Bogdański, Pawel; Comlekci, Abdurrahman; Consoli, Agostino; Deerochanawong, Chaicharn; Dungan, Kathleen; Faingold, Maria C.; Farkouh, Michael E.; Franco, Denise R.; Gram, Jeppe; Guja, Cristian; Joshi, Pankaj; Malek, Rachid; Merino‐Torres, J... Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 3(2019) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗